NCT07152041 2025-09-03CAMS-Ph+ B-ALLInstitute of Hematology & Blood Diseases Hospital, ChinaPhase 3 Recruiting150 enrolled
NCT06640361 2024-12-27A Study of Olverembatinib in SDH-deficient GIST.Ascentage Pharma Group Inc.Phase 3 Recruiting40 enrolled